BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4214836)

  • 1. Sanfilippo A syndrome: sulfamidase deficiency in cultured skin fibroblasts and liver.
    Matalon R; Dorfman A
    J Clin Invest; 1974 Oct; 54(4):907-12. PubMed ID: 4214836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligosaccharide substrates for heparin sulfamidase.
    Thompson JN; Rodén L; Reynertson R
    Anal Biochem; 1986 Feb; 152(2):412-22. PubMed ID: 3083713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharide storage diseases and lysosomal hydrolases in cultured fibroblasts.
    den Tandt WR; Schaberg A
    Pathol Eur; 1973; 8(1):3-11. PubMed ID: 4269628
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
    Perkins KJ; Muller V; Weber B; Hopwood JJ
    Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).
    Fischer A; Carmichael KP; Munnell JF; Jhabvala P; Thompson JN; Matalon R; Jezyk PF; Wang P; Giger U
    Pediatr Res; 1998 Jul; 44(1):74-82. PubMed ID: 9667374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective heparan sulfate metabolism in the Sanfilippo syndrome and assay of this defect in the assessment of the mucopolysaccharidoses patient.
    Gordon BA; Feleki V; Budreau CH; Tyler L
    Clin Biochem; 1975 Jun; 8(3):184-93. PubMed ID: 238759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabelled oligosaccharides as substrates for the estimation of sulfamidase and the detection of the Sanfilippo type A syndrome.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1981 Apr; 112(1):55-66. PubMed ID: 6786803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of sulfate-containing acid mucopolysaccharides in I-cell fibroblasts.
    Schmickel RD; Distler JJ; Jourdian GW
    J Lab Clin Med; 1975 Oct; 86(4):672-82. PubMed ID: 170349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sanfilippo syndrome, type D: a spectrophotometric assay with prenatal diagnostic potential.
    Nowakowski RW; Thompson JN; Taylor KB
    Pediatr Res; 1989 Nov; 26(5):462-6. PubMed ID: 2510119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidosis 3 A (Sanfilippo A disease): deficiency of a heparin sulfamidase in skin fibroblasts and leucocytes.
    Kresse H
    Biochem Biophys Res Commun; 1973 Oct; 54(3):1111-8. PubMed ID: 4201808
    [No Abstract]   [Full Text] [Related]  

  • 11. A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients.
    Kresse H; Von Figura K; Klein U
    Eur J Biochem; 1978 Dec; 92(2):333-9. PubMed ID: 153835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A screening method for mucopolysaccharidoses with increased urinary excretion of sulfated N-acetylhexosamines.
    Nowakowski RW; Thompson JN; Edge DS
    Biochem Int; 1990 Nov; 22(3):419-26. PubMed ID: 2127527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1982 Aug; 123(3):241-50. PubMed ID: 6811162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L; Dietrich CP; Nader HB
    Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients.
    O'Brien JS
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1720-2. PubMed ID: 4261742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative aspects of pinocytosis and the intracellular fate of N-acetyl-alpha-D-glucosaminidase in Sanfilippo B fibroblasts.
    von Figura K; Kresse H
    J Clin Invest; 1974 Jan; 53(1):85-90. PubMed ID: 4271574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidosis III A (Sanfilippo disease type A). Histochemical, electron microscopical and biochemical findings.
    Cain H; Egner E; Kresse H
    Beitr Pathol; 1977 Apr; 160(1):58-72. PubMed ID: 405006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.
    Klein U; Kresse H; von Figura K
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5185-9. PubMed ID: 33384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosidases in human skin fibroblast cultures. Alpha-fucosidase, alpha-galactosidase, alpha-glucosidase, beta-mannosidase, and N-acetyl-alpha-glucosaminidase.
    Hultberg B; Sjöblad S; Ockerman PA
    Acta Paediatr Scand; 1975 Jan; 64(1):123-31. PubMed ID: 234663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.
    Kresse H; Paschke E; von Figura K; Gilberg W; Fuchs W
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6822-6. PubMed ID: 6450420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.